Efficacy of Henagliflozin for Weight Loss in Obesity Without Diabetes

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

October 1, 2026

Conditions
ObeseWeight LossPre-diabetes
Interventions
DRUG

Henagliflozin

10mg of Henagliflozin and diet-exercise therapy

DRUG

Placebo

Placebo and diet-exercise therapy

All Listed Sponsors
collaborator

The Second Hospital of Nanjing Medical University

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

Second Affiliated Hospital of Soochow University

OTHER

collaborator

Wuxi People's Hospital

OTHER

collaborator

Northern Jiangsu People's Hospital

OTHER

collaborator

The Affiliated Hospital of Xuzhou Medical University

OTHER

collaborator

The First People's Hospital of Lianyungang

OTHER

collaborator

Affiliated Hospital of Jiangsu University

OTHER

collaborator

The fourth affiliated hospital of nantong university

UNKNOWN

lead

The First People's Hospital of Changzhou

OTHER